Mind Medicine (MindMed) Inc. Stock Deutsche Boerse AG
Equities
MMQ
CA60255C8850
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 EUR | +2.44% | +3.51% | +148.23% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 678M 633M 930M |
---|---|---|---|---|---|
Net income 2024 * | -94M -87.75M -129M | Net income 2025 * | -106M -98.95M -146M | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 172M 253M | Net cash position 2025 * | 99.5M 92.88M 137M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.94
x | P/E ratio 2025 * |
-6.43
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.41% |
Latest transcript on Mind Medicine (MindMed) Inc.
1 day | +2.44% | ||
1 week | +3.51% | ||
Current month | -1.87% | ||
1 month | -1.87% | ||
3 months | +139.86% | ||
6 months | +252.94% | ||
Current year | +148.23% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 21-01-13 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22-05-22 |
Miri Wernli
PSD | President | 71 | 20-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 21-09-28 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 22-08-10 |
David Gryska
BRD | Director/Board Member | 68 | 23-06-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 8.4 | +2.44% | 150 |
24-04-29 | 8.2 | +4.26% | 37 |
24-04-26 | 7.865 | +0.13% | 0 |
24-04-25 | 7.855 | -3.02% | 253 |
24-04-24 | 8.1 | +0.37% | 337 |
Delayed Quote Deutsche Boerse AG, April 30, 2024 at 04:29 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- MNMD Stock
- MMQ Stock